Imagine never having to wear your glasses or contacts in the light of day again. If you haven’t had 20/20 vision since grade school, that’s a big deal. Now imagine a technology that could decrease the ...
RARITAN, N.J., May 3, 2021 /CNW/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ORTHO ...
New Menu Capability Now Available on VISION and VISION MAX Analyzers Increases Confidence in Blood Transfusion-Related Test Results RARITAN, N.J., Sept. 27, 2021 /PRNewswire/ -- Ortho Clinical ...
RARITAN, NJ--(Marketwired - Aug 18, 2015) - Ortho Clinical Diagnostics today announced that it obtained 510(k) clearance for the ORTHO VISION™ Analyzer, a highly interactive, fully automated analyzer ...
RARITAN, NJ--(Marketwired - Apr 28, 2016) - Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that ORTHO™ Sera, a fully automated solution for extended ...
Imagine never having to wear your glasses or contacts in the light of day again. If you haven’t had 20/20 vision since grade school, that’s a big deal. Now imagine a technology that could decrease the ...
Further, Ortho Clinical Diagnostics is powered by Ortho Care™, a global, award-winning, holistic service and support program designed to empower laboratorians to take full advantage of Ortho's ...
RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback